Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
42 "Pancreas"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Article image
Welcoming the new, revisiting the old: a brief glance at cytopathology reporting systems for lung, pancreas, and thyroid
Rita Luis, Balamurugan Thirunavukkarasu, Deepali Jain, Sule Canberk
J Pathol Transl Med. 2024;58(4):165-173.   Published online July 15, 2024
DOI: https://doi.org/10.4132/jptm.2024.06.11
  • 822 View
  • 204 Download
AbstractAbstract PDF
This review addresses new reporting systems for lung and pancreatobiliary cytopathology as well as the most recent edition of The Bethesda Reporting System for Thyroid Cytopathology. The review spans past, present, and future aspects within the context of the intricate interplay between traditional morphological assessments and cutting-edge molecular diagnostics. For lung and pancreas, the authors discuss the evolution of reporting systems, emphasizing the bridge between past directives and more recent collaborative efforts of the International Academy of Cytology and the World Health Organization in shaping universal reporting systems. The review offers a brief overview of the structure of these novel systems, highlighting their strengths and pinpointing areas that require further refinement. For thyroid, the authors primarily focus on the third edition of The Bethesda System for Reporting Thyroid Cytopathology, also considering the two preceding editions. This review serves as an invaluable resource for cytopathologists, offering a panoramic view of the evolving landscape of cytopathology reporting and pointing out the integrative role of the cytopathologist in an era of rapid diagnostic and therapeutic advancements.
Case Study
Article image
Malignant potential of neuroendocrine microtumor of the pancreas harboring high-grade transformation: lesson learned from a patient with von Hippel-Lindau syndrome
Jongwon Lee, Kyung Jin Lee, Dae Wook Hwang, Seung-Mo Hong
J Pathol Transl Med. 2024;58(2):91-97.   Published online March 13, 2024
DOI: https://doi.org/10.4132/jptm.2024.02.13
  • 1,302 View
  • 176 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDF
Pancreatic neuroendocrine microtumor (PNEMT) is a neuroendocrine tumor (NET) < 0.5 cm in diameter, and it is considered benign. We report a PNEMT with high-grade transformation (HGT). A man in his 60s with von Hippel-Lindau syndrome underwent surgical resection of a NET. A second sub-centimeter nodule with a nodule-in-nodule pattern was discovered. The 0.4 cm outer nodule contained clear columnar cells with round nuclei and indistinct nucleoli, while the 0.1 cm inner nodule had eosinophilic cells with an increased nuclear to cytoplasmic ratio, vesicular nuclei, and prominent nucleoli. Tumor cells in the outer and inner nodules were synaptophysin and chromogranin positive. Only the inner nodule was p53 positive, while the outer nodule was exclusively positive for carbonic anhydrase 9 and vimentin. The Ki-67 labeling indices for the outer and inner nodules were 2.1% (grade 1) and 44.3% (grade 3), respectively. This nodule was determined to be a PNEMT with HGT. Our findings suggest that a PNEMT may not always be benign and can undergo HGT.

Citations

Citations to this article as recorded by  
  • Molecular Basis of Pancreatic Neuroendocrine Tumors
    Alesia Maluchenko, Denis Maksimov, Zoia Antysheva, Julia Krupinova, Ekaterina Avsievich, Olga Glazova, Natalia Bodunova, Nikolay Karnaukhov, Ilia Feidorov, Diana Salimgereeva, Mark Voloshin, Pavel Volchkov
    International Journal of Molecular Sciences.2024; 25(20): 11017.     CrossRef
Original Articles
Article image
Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas
Jaehoon Shin, Seungbeom Shin, Jae Hoon Lee, Ki Byung Song, Dae Wook Hwang, Hyoung Jung Kim, Jae Ho Byun, HyungJun Cho, Song Cheol Kim, Seung-Mo Hong
J Pathol Transl Med. 2020;54(5):387-395.   Published online July 21, 2020
DOI: https://doi.org/10.4132/jptm.2020.06.23
  • 7,766 View
  • 124 Download
  • 12 Web of Science
  • 9 Crossref
AbstractAbstract PDF
Background
Although lymph node metastasis is a poor prognostic factor in patients with pancreatic ductal adenocarcinoma (PDAC), our understanding of lymph node size in association with PDAC is limited. Increased nodal size in preoperative imaging has been used to detect node metastasis. We evaluated whether lymph node size can be used as a surrogate preoperative marker of lymph node metastasis.
Methods
We assessed nodal size and compared it to the nodal metastatic status of 200 patients with surgically resected PDAC. The size of all lymph nodes and metastatic nodal foci were measured along the long and short axis, and the relationships between nodal size and metastatic status were compared at six cutoff points.
Results
A total of 4,525 lymph nodes were examined, 9.1% of which were metastatic. The mean size of the metastatic nodes (long axis, 6.9±5.0 mm; short axis, 4.3±3.1 mm) was significantly larger than that of the non-metastatic nodes (long axis, 5.0±4.0 mm; short axis, 3.0±2.0 mm; all p<.001). Using a 10 mm cutoff, the sensitivity, specificity, positive predictive value, overall accuracy, and area under curve was 24.8%, 88.0%, 17.1%, 82.3%, and 0.60 for the long axis and 7.0%, 99.0%, 40.3%, 90.6%, and 0.61 for the short axis, respectively.
Conclusions
The metastatic nodes are larger than the non-metastatic nodes in PDAC patients. However, the difference in nodal size was too small to be identified with preoperative imaging. The performance of preoperative radiologic imaging to predict lymph nodal metastasis was not good. Therefore, nodal size cannot be used a surrogate preoperative marker of lymph node metastasis.

Citations

Citations to this article as recorded by  
  • Long‐term outcomes of neoadjuvant gemcitabine, nab‐paclitaxel, and S1 (GAS) in borderline resectable pancreatic cancer with arterial contact: Results from a phase II trial
    Kenichiro Uemura, Naru Kondo, Takeshi Sudo, Tatsuaki Sumiyoshi, Ryuta Shintakuya, Kenjiro Okada, Kenta Baba, Takumi Harada, Yoshiaki Murakami, Shinya Takahashi
    Journal of Hepato-Biliary-Pancreatic Sciences.2024; 31(5): 351.     CrossRef
  • Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma
    Piaoe Zeng, Chao Qu, Jianfang Liu, Jingjing Cui, Xiaoming Liu, Dianrong Xiu, Huishu Yuan
    Acta Radiologica.2023; 64(7): 2221.     CrossRef
  • Prevalence of Adenopathy at Chest Computed Tomography After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2
    Georgeann McGuinness, Jeffrey B. Alpert, Geraldine Brusca-Augello, Lea Azour, Jane P. Ko, Farah Tamizuddin, Elliott K. Gozansky, William H. Moore
    Journal of Computer Assisted Tomography.2023; 47(1): 50.     CrossRef
  • Predictive role of radiomics features extracted from preoperative cross-sectional imaging of pancreatic ductal adenocarcinoma in detecting lymph node metastasis: a systemic review and meta-analysis
    Mohammad Mirza-Aghazadeh-Attari, Seyedeh Panid Madani, Haneyeh Shahbazian, Golnoosh Ansari, Alireza Mohseni, Ali Borhani, Shadi Afyouni, Ihab R. Kamel
    Abdominal Radiology.2023; 48(8): 2570.     CrossRef
  • Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
    Ja Kyung Yoon, Mi-Suk Park, Seung-Seob Kim, Kyunghwa Han, Hee Seung Lee, Seungmin Bang, Ho Kyoung Hwang, Sang Hyun Hwang, Mijin Yun, Myeong-Jin Kim
    Scientific Reports.2022;[Epub]     CrossRef
  • Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
    Alessandro Coppola, Vincenzo La Vaccara, Tommaso Farolfi, Michele Fiore, Roberto Cammarata, Sara Ramella, Roberto Coppola, Damiano Caputo
    Biomedicines.2022; 10(9): 2091.     CrossRef
  • Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer
    Huapyong Kang, Seung-seob Kim, Min Je Sung, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Mi-Suk Park, Seungmin Bang
    Cancers.2022; 14(19): 4672.     CrossRef
  • Does direct invasion of peripancreatic lymph nodes impact survival in patients with pancreatic ductal adenocarcinoma? A retrospective dual-center study
    Daisuke Hashimoto, Sohei Satoi, Mitsuaki Ishida, Kenji Nakagawa, Masaya Kotsuka, Tadataka Takagi, Hironori Ryota, Taichi Terai, Tatsuma Sakaguchi, Minako Nagai, So Yamaki, Takahiro Akahori, Tomohisa Yamamoto, Mitsugu Sekimoto, Masayuki Sho
    Pancreatology.2021; 21(5): 884.     CrossRef
  • CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
    Alessandro Coppola, Vincenzo La Vaccara, Michele Fiore, Tommaso Farolfi, Sara Ramella, Silvia Angeletti, Roberto Coppola, Damiano Caputo
    Frontiers in Oncology.2021;[Epub]     CrossRef
Article image
Sarcoma metastasis to the pancreas: experience at a single institution
Miseon Lee, Joon Seon Song, Seung-Mo Hong, Se Jin Jang, Jihun Kim, Ki Byung Song, Jae Hoon Lee, Kyung-Ja Cho
J Pathol Transl Med. 2020;54(3):220-227.   Published online April 22, 2020
DOI: https://doi.org/10.4132/jptm.2020.03.04
  • 6,023 View
  • 158 Download
  • 8 Web of Science
  • 10 Crossref
AbstractAbstract PDF
Background
Reports of metastatic sarcoma to the pancreas are limited. We reviewed the clinicopathologic characteristics of such cases.
Methods
We reviewed 124 cases of metastatic tumors to the pancreas diagnosed at Asan Medical Center between 2000 and 2017.
Results
Metastatic tumors to the pancreas consisted of 111 carcinomas (89.5%), 12 sarcomas (9.6%), and one melanoma (0.8%). Primary sarcoma sites were bone (n = 4); brain, lung, and soft tissue (n = 2 for each); and the uterus and pulmonary vein (n = 1 for each). Pathologically, the 12 sarcomas comprised 2 World Health Organization grade III solitary fibrous tumors/hemangiopericytomas, and one case each of synovial sarcoma, malignant solitary fibrous tumor, undifferentiated pleomorphic sarcoma, osteosarcoma, mesenchymal chondrosarcoma, intimal sarcoma, myxofibrosarcoma, myxoid liposarcoma, rhabdomyosarcoma, subtype uncertain, and high-grade spindle-cell sarcoma of uncertain type. The median interval between primary cancer diagnosis and pancreatic metastasis was 28.5 months. One case manifested as a solitary pancreatic osteosarcoma metastasis 15 months prior to detection of osteosarcoma in the femur and was initially misdiagnosed as sarcomatoid carcinoma of the pancreas.
Conclusions
The metastatic sarcoma should remain a differential diagnosis when spindle-cell malignancy is found in the pancreas, even for solitary lesions or in patients without prior history.

Citations

Citations to this article as recorded by  
  • Metastatic clear cell sarcoma of the pancreas: A sporadic cancer
    Vittorio Gebbia, Carlo Carnaghi
    World Journal of Clinical Cases.2024; 12(18): 3291.     CrossRef
  • Metastatic clear cell sarcoma of the pancreas: An overview
    Rachid Ait Addi
    World Journal of Clinical Cases.2024; 12(29): 6262.     CrossRef
  • Myxofibrosarcoma with pancreatic metastasis, a case report and literature reviews
    Kodai ABE, Yasutomo SEKIDO, Yasuo KABESHIMA
    Suizo.2024; 39(5): 334.     CrossRef
  • Metástasis pancreática de sarcoma, un hallazgo infrecuente
    Daniel Aparicio-López, Jorge Chóliz-Ezquerro, Carlos Hörndler-Algárate, Mario Serradilla-Martín
    Gastroenterología y Hepatología.2023; 46(5): 376.     CrossRef
  • Pancreatic metastasis from sarcoma, an infrequent finding
    Daniel Aparicio-López, Jorge Chóliz-Ezquerro, Carlos Hörndler-Algárate, Mario Serradilla-Martín
    Gastroenterología y Hepatología (English Edition).2023; 46(5): 376.     CrossRef
  • Acute pancreatitis secondary to osteosarcoma metastasis
    Pablo Salmón Olavarría, Ana Gordo Ortega, Maren Eizagirre Ubegun, Verónica Ubieto Capella, Elena Carracedo Vega, Juan Carrascosa Gil, David Ruiz-Clavijo García
    Revista Española de Enfermedades Digestivas.2023;[Epub]     CrossRef
  • First Recurrence of Synovial Sarcoma Presenting With Solitary Pancreatic Mass
    Raja R Narayan, Greg W Charville, Daniel Delitto, Kristen N Ganjoo
    Cureus.2022;[Epub]     CrossRef
  • Intravenous Leiomyosarcoma of the Lower Extremity: As Peripheral as It Gets
    Levent F Umur, Selami Cakmak, Mehmet Isyar, Hamdi Tokoz
    Cureus.2021;[Epub]     CrossRef
  • Could the burden of pancreatic cancer originate in childhood?
    Smaranda Diaconescu, Georgiana Emmanuela Gîlcă-Blanariu, Silvia Poamaneagra, Otilia Marginean, Gabriela Paduraru, Gabriela Stefanescu
    World Journal of Gastroenterology.2021; 27(32): 5322.     CrossRef
  • Staged Surgical Resection of Primary Pulmonary Synovial Sarcoma with Synchronous Multiple Pancreatic Metastases: Report of a Rare Case and Review of the Literature
    Panagiotis Dorovinis, Nikolaos Machairas, Stylianos Kykalos, Paraskevas Stamopoulos, George Agrogiannis, Nikolaos Nikiteas, Georgios C. Sotiropoulos
    Journal of Gastrointestinal Cancer.2021; 52(3): 1151.     CrossRef
Case Study
Coexisting Mucinous Cystic Neoplasm of the Pancreas and Type 1 Autoimmune Pancreatitis
Mee-Jeong Kim, Tae Jun Song, Hyoung Jung Kim, Song-Cheol Kim, Myung-Hwan Kim, Seung-Mo Hong
J Pathol Transl Med. 2019;53(2):125-128.   Published online November 14, 2018
DOI: https://doi.org/10.4132/jptm.2018.10.25
  • 8,266 View
  • 121 Download
  • 3 Web of Science
  • 6 Crossref
AbstractAbstract PDF
Type 1 autoimmune pancreatitis (AIP1) is an IgG4-related systemic disease that mimics tumors. We report a rare case of AIP1 accompanied by mucinous cystic neoplasm (MCN). A pancreatic lesion was incidentally detected in a woman in her 60s. After 6 years of follow-up, the lesion abruptly increased in size. Computed tomography showed a 3.5 cm unilocular cyst in the tail of the pancreas and distal pancreatectomy was performed. On microscopic examination, the cyst was lined by mucinous and non-mucinous epithelial cells with mild cytologic atypia. The surrounding stroma comprised ovarian-type spindle cells with progesterone receptor positivity. The pericystic pancreas exhibited multifocal lymphoid follicles, lymphoplasmacytic infiltrations, obliterative phlebitis, and storiform fibrosis. IgG4-positive plasma cell infiltration (215 cells high-power field) and the IgG4/IgG ratio (57%) were increased. Cases of MCN coexisting with AIP1 are extremely rare; only two such cases have been reported in the English-language literature. This third case featured low-grade MCN with AIP1.

Citations

Citations to this article as recorded by  
  • Utilizing Immunoglobulin G4 Immunohistochemistry for Risk Stratification in Patients with Papillary Thyroid Carcinoma Associated with Hashimoto Thyroiditis
    Faridul Haq, Gyeongsin Park, Sora Jeon, Mitsuyoshi Hirokawa, Chan Kwon Jung
    Endocrinology and Metabolism.2024; 39(3): 468.     CrossRef
  • Histological features of autoimmune pancreatitis and IgG4-related sclerosing cholangitis with a correlation with imaging findings
    Kenji NOTOHARA
    Choonpa Igaku.2023; 50(1): 55.     CrossRef
  • Imaging Features and Risk Factors of Pancreatic Cystic Lesions Complicating Autoimmune Pancreatitis: A Retrospective Study
    Bin-Bin Zhang, Xin-Meng Hou, Yu-Qi Chen, Jian-Wei Huo, Er-Hu Jin
    Current Medical Imaging Formerly Current Medical Imaging Reviews.2023;[Epub]     CrossRef
  • Histological features of autoimmune pancreatitis and IgG4-related sclerosing cholangitis with a correlation with imaging findings
    Kenji Notohara
    Journal of Medical Ultrasonics.2021; 48(4): 581.     CrossRef
  • 自己免疫性膵炎診療ガイドライン2020

    Suizo.2020; 35(6): 465.     CrossRef
  • Mucinous cystic neoplasm of the pancreas with type-1 autoimmune pancreatitis-like lesion
    Kevin Gowing, David F. Schaeffer, Hui-Min Yang
    Human Pathology: Case Reports.2019; 18: 200339.     CrossRef
Original Article
Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients
Sung Joo Kim, Soyeon An, Jae Hoon Lee, Joo Young Kim, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong
J Pathol Transl Med. 2017;51(4):388-395.   Published online June 8, 2017
DOI: https://doi.org/10.4132/jptm.2017.03.19
  • 6,893 View
  • 136 Download
  • 17 Web of Science
  • 16 Crossref
AbstractAbstract PDF
Background
Pancreatic neuroendocrine tumors (PanNETs) are the second most common pancreatic neoplasms and there is no well-elucidated biomarker to stratify their detection and prognosis. Previous studies have reported that progesterone receptor (PR) expression status was associated with poorer survival in PanNET patients.
Methods
To validate previous studies, PR protein expression was assessed in 21 neuroendocrine microadenomas and 277 PanNETs and compared with clinicopathologic factors including patient survival.
Results
PR expression was gradually decreased from normal islets (49/49 cases, 100%) to neuroendocrine microadenoma (14/21, 66.6%) to PanNETs (60/277, 21.3%; p < .001). PanNETs with loss of PR expression were associated with increased tumor size (p < .001), World Health Organization grade (p = .001), pT classification (p < .001), perineural invasion (p = .028), lymph node metastasis (p = .004), activation of alternative lengthening of telomeres (p = .005), other peptide hormonal expression (p < .001) and ATRX/DAXX expression (p = .015). PanNET patients with loss of PR expression (5-year survival rate, 64.1%) had significantly poorer recurrence-free survival outcomes than those with intact PR expression (90%) by univariate (p = .012) but not multivariate analyses. Similarly, PanNET patients with PR expression loss (5-year survival rate, 76%) had significantly poorer overall survival by univariate (p = .015) but not multivariate analyses.
Conclusions
Loss of PR expression was noted in neuroendocrine microadenomas and was observed in the majority of PanNETs. This was associated with increased grade, tumor size, and advanced pT and pN classification; and was correlated with decreased patient survival time by univariate but not multivariate analyses. Loss of PR expression can provide additional information on shorter disease-free survival in PanNET patients.

Citations

Citations to this article as recorded by  
  • Sex Differences in the Survival of Patients with Neuroendocrine Neoplasms: A Comparative Study of Two National Databases
    Mohamed Mortagy, Marie Line El Asmar, Kandiah Chandrakumaran, John Ramage
    Cancers.2024; 16(13): 2376.     CrossRef
  • Association Between Female Sex and Better Survival in Gastroenteropancreatic Neuroendocrine Tumors
    Jeremy Chang, Mohammed O. Suraju, Catherine G. Tran, Carlos H.F. Chan, Po Hien Ear, James R. Howe, Scott K. Sherman
    Journal of Surgical Research.2024; 302: 53.     CrossRef
  • Incidence and Prognostic Implications of Lymphovascular Invasion in Node‐Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group
    Kota Sahara, Diamantis I. Tsilimigras, Yuki Homma, Jun Kawashima, Shishir K. Maithel, Flavio Rocha, Sharon Weber, Ryan Fields, Kamran Idrees, George A. Poultsides, Cliff Cho, Itaru Endo, Timothy M. Pawlik
    Journal of Surgical Oncology.2024;[Epub]     CrossRef
  • Venous invasion and lymphatic invasion are correlated with the postoperative prognosis of pancreatic neuroendocrine neoplasm
    Sho Kiritani, Junichi Arita, Yuichiro Mihara, Rihito Nagata, Akihiko Ichida, Yoshikuni Kawaguchi, Takeaki Ishizawa, Nobuhisa Akamatsu, Junichi Kaneko, Kiyoshi Hasegawa
    Surgery.2023; 173(2): 365.     CrossRef
  • Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine Tumor
    Bokyung Ahn, Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2023; 147(1): 100.     CrossRef
  • HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
    Milton J. Barros, Jonathan Strosberg, Taymeyah Al-Toubah, Victor Hugo F. de Jesus, Lais Durant, Celso A. Mello, Tiago C. Felismino, Louise De Brot, Rodrigo G. Taboada, Mauro D. Donadio, Rachel P. Riechelmann
    Therapeutic Advances in Medical Oncology.2023;[Epub]     CrossRef
  • Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors
    Florian Viehweger, Lisa-Marie Tinger, David Dum, Natalia Gorbokon, Anne Menz, Ria Uhlig, Franziska Büscheck, Andreas M. Luebke, Claudia Hube-Magg, Andrea Hinsch, Doris Höflmayer, Christoph Fraune, Patrick Lebok, Sören Weidemann, Maximilian Lennartz, Frank
    Analytical Cellular Pathology.2022; 2022: 1.     CrossRef
  • Prognostic Nomograms to Predict Overall Survival and Cancer-Specific Survival of Patients With Pancreatic Neuroendocrine Tumors
    Zuoli Song, Sumei Wang, Yujing Wu, Jinjuan Zhang, Shuye Liu
    Pancreas.2021; 50(3): 414.     CrossRef
  • Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study
    Haeryoung Kim, Soyeon An, Kyoungbun Lee, Sangjeong Ahn, Do Youn Park, Jo-Heon Kim, Dong-Wook Kang, Min-Ju Kim, Mee Soo Chang, Eun Sun Jung, Joon Mee Kim, Yoon Jung Choi, So-Young Jin, Hee Kyung Chang, Mee-Yon Cho, Yun Kyung Kang, Myunghee Kang, Soomin Ahn
    Cancer Research and Treatment.2020; 52(1): 263.     CrossRef
  • Systemic distribution of progesterone receptor subtypes in human tissues
    Teeranut Asavasupreechar, Ryoko Saito, Yasuhiro Miki, Dean P. Edwards, Viroj Boonyaratanakornkit, Hironobu Sasano
    The Journal of Steroid Biochemistry and Molecular Biology.2020; 199: 105599.     CrossRef
  • Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms
    Tomoyoshi Tachibana, Atsuko Kasajima, Takeshi Aoki, Tomoaki Tabata, Keely McNamara, Samaneh Yazdani, Sato Satoko, Fumiyoshi Fujishima, Fuyuhiko Motoi, Michiaki Unno, Hironobu Sasano
    The Journal of Steroid Biochemistry and Molecular Biology.2020; 201: 105694.     CrossRef
  • Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
    Lingaku Lee, Tetsuhide Ito, Robert T Jensen
    Expert Review of Anticancer Therapy.2019; 19(12): 1029.     CrossRef
  • Immunohistochemistry, carcinomas of unknown primary, and incidence rates
    Edward B. Stelow, Hadi Yaziji
    Seminars in Diagnostic Pathology.2018; 35(2): 143.     CrossRef
  • Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival
    Joo Young Kim, Sang Hwa Lee, Soyeon An, Sung Joo Kim, You-Na Sung, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Seung-Mo Hong
    Virchows Archiv.2018; 472(5): 739.     CrossRef
  • Prognostic value of progesterone receptor in solid pseudopapillary neoplasm of the pancreas: evaluation of a pooled case series
    Feiyang Wang, Zibo Meng, Shoukang Li, Yushun Zhang, Heshui Wu
    BMC Gastroenterology.2018;[Epub]     CrossRef
  • Estrogens modulate progesterone receptor expression and may contribute to progesterone-mediated apoptotic β-cell death
    Viviane Abreu Nunes
    Endocrinology&Metabolism International Journal.2018;[Epub]     CrossRef
Review
Article image
Cytology Specimen Management, Triage and Standardized Reporting of Fine Needle Aspiration Biopsies of the Pancreas
Won Jae Yoon, Martha Bishop Pitman
J Pathol Transl Med. 2015;49(5):364-372.   Published online August 10, 2015
DOI: https://doi.org/10.4132/jptm.2015.07.19
  • 12,464 View
  • 140 Download
  • 7 Web of Science
  • 8 Crossref
AbstractAbstract PDF
The recent advances in pancreas cytology specimen sampling methods have enabled a specific cytologic diagnosis in most cases. Proper triage and processing of the cytologic specimen is pivotal in making a diagnosis due to the need for ancillary testing in addition to cytological evaluation, which is especially true in the diagnosis of pancreatic cysts. Newly proposed terminology for pancreaticobiliary cytology offers a standardized language for reporting that aims to improve communication among patient caregivers and provide for increased flexibility in patient management. This review focuses on these updates in pancreas cytology for the optimal evaluation of solid and cystic lesions of the pancreas.

Citations

Citations to this article as recorded by  
  • Imaging of pancreatic serous cystadenoma and common imitators
    Camila Lopes Vendrami, Nancy A. Hammond, David J. Escobar, Zachary Zilber, Meaghan Dwyer, Courtney C. Moreno, Pardeep K. Mittal, Frank H. Miller
    Abdominal Radiology.2024; 49(10): 3666.     CrossRef
  • “Evolving Trends in Pancreatic Cystic Tumors: A 3-Decade Single-Center Experience With 1290 Resections”
    Jorge Roldán, Jon M. Harrison, Motaz Qadan, Louisa Bolm, Taisuke Baba, William R. Brugge, Brenna W. Casey, Kumar Krishnan, Mari Mino-Kenudson, Martha B. Pitman, Avinash Kambadakone, Cristina R. Ferrone, Andrew L. Warshaw, Keith D. Lillemoe, Carlos Fernánd
    Annals of Surgery.2023; 277(3): 491.     CrossRef
  • Role of fluorescence confocal microscopy for rapid evaluation of EUS fine-needle biopsy sampling in pancreatic solid lesions
    Serena Stigliano, Anna Crescenzi, Chiara Taffon, Francesco Covotta, Cesare Hassan, Giulio Antonelli, Martina Verri, Dario Biasutto, Roberto Mario Scarpa, Francesco Maria Di Matteo
    Gastrointestinal Endoscopy.2021; 94(3): 562.     CrossRef
  • Towards optimal pancreatic cyst fluid management: the need for standardisation
    Giacomo Puppa, Yann Christinat, Thomas Alexander McKee
    Gut.2019; 68(10): 1906.     CrossRef
  • It is necessary to exam bottom and top slide smears of EUS-FNA for pancreatic cancer
    Jong-chan Lee, Haeryoung Kim, Hyoung Woo Kim, Jongchan Lee, Kyu-hyun Paik, Jingu Kang, Jin-Hyeok Hwang, Jaihwan Kim
    Hepatobiliary & Pancreatic Diseases International.2018; 17(6): 553.     CrossRef
  • Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer
    Milosz Wiktorowicz, Damian Mlynarski, Radoslaw Pach, Romana Tomaszewska, Jan Kulig, Piotr Richter, Marek Sierzega
    Pancreatology.2018; 18(8): 977.     CrossRef
  • Variations in cancer centers’ use of cytology for the diagnosis of unresectable pancreatic cancer in the National Cancer Data Base
    Ted Gansler, Stacey A. Fedewa, Chun Chieh Lin, Ahmedin Jemal, Elizabeth M. Ward
    Cancer Cytopathology.2016; 124(11): 791.     CrossRef
  • Pancreatic Cytopathology
    Jennifer A. Collins, Syed Z. Ali, Christopher J. VandenBussche
    Surgical Pathology Clinics.2016; 9(4): 661.     CrossRef
Original Articles
Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Lesions
Hae Woon Baek, Min Jee Park, Ye-Young Rhee, Kyoung Bun Lee, Min A Kim, In Ae Park
J Pathol Transl Med. 2015;49(1):52-60.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.26
  • 9,366 View
  • 84 Download
  • 31 Web of Science
  • 32 Crossref
AbstractAbstract PDF
Background
Endoscopic ultrasound–guided fine needle aspiration cytology (EUS-FNAC) is currently the most commonly used procedure for obtaining cytologic specimens of the pancreas. It is accurate, minimally invasive, safe and cost-effective. However, there is discrepancy between cytological and surgical diagnoses. This study was aimed at evaluating the diagnostic accuracy of EUS-FNAC of the pancreas. Methods: We performed a retrospective review of 191 cases of pancreatic lesions initially diagnosed by EUS-FNAC with subsequent histological diagnosis between 2010 and 2012 in the Department of Pathology, Seoul National University Hospital. Cytologic and surgical diagnoses were categorized into five groups: negative, benign, atypical, malignant, and insufficient for diagnosis. Subsequently, 167 cases with satisfactory yield in both surgical and cytology specimens were statistically analyzed to determine correlations with diagnosis. Results: In comparison to surgical diagnoses, cytologic diagnoses were true-positive in 103 cases (61.7%), true-negative in 28 cases (16.8%), false-positive in 9 cases (5.4%), and false-negative in 27 cases (16.1%). The diagnostic accuracy was 78.4%, sensitivity was 79.2%, and specificity was 75.7%. The positive predictive value was 92.0%, and negative predictive value was 50.9%. Conclusions: EUS-FNAC has high accuracy, sensitivity, specificity and positive predictive value. Overcoming the limitations of EUS-FNAC will make it a useful and reliable diagnostic tool for accurate evaluation of pancreatic lesions.

Citations

Citations to this article as recorded by  
  • Reporting Pancreatic FNAC using the Papanicolaou System: Still a Diagnostic Challenge
    Parul Verma, Saloni Goyal, Ruchita Tyagi, Mehar Ghuman, Ramit Mahajan, Arshneet Kaur Selhi, Harpreet Kaur, Pavneet Kaur Selhi
    Journal of Cytology.2024; 41(2): 123.     CrossRef
  • miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic
    Hiroki Ueda, Hidenori Takahashi, Shogo Kobayashi, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi
    Annals of Surgical Oncology.2024;[Epub]     CrossRef
  • Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysis
    Hiroki Ueda, Hidenori Takahashi, Ryoto Sakaniwa, Tetsuhisa Kitamura, Shogo Kobayashi, Yoshito Tomimaru, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi
    Pancreatology.2024; 24(7): 1097.     CrossRef
  • Comparison of Endoscopic Ultrasound-Guided Fine-Needle Aspiration with Fine-Needle Biopsy for Solid Gastrointestinal Lesions: A Randomized Crossover Single-Center study
    Shivaraj Afzalpurkar, Vijay Kumar Rai, Nikhil Sonthalia, Gajanan Rodge, Awanesh Tewary, Mahesh Goenka
    Journal of Digestive Endoscopy.2023; 14(01): 014.     CrossRef
  • Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
    María Victoria García-Ortiz, Pablo Cano-Ramírez, Marta Toledano-Fonseca, Enrique Aranda, Antonio Rodríguez-Ariza
    Biomarker Research.2023;[Epub]     CrossRef
  • Grading pancreatic adenocarcinomas on fine needle aspiration cytology. The outstanding issues
    Mrinmay Kumar Mallik, Laila Rafiq Qadan, Asit Kumar Mohanty, Ali Alali, Kusum Kapila
    Cytopathology.2023;[Epub]     CrossRef
  • The impact of preoperative EUS-FNA for distal resectable pancreatic cancer: Is it really effective enough to take risks?
    Jin-Seok Park, Jae Hoon Lee, Tae Jun Song, Joune Seup Lee, Seok Jung Jo, Dong Wook Oh, Ki Byung Song, Dae Wook Hwang, Do Hyun Park, Sang Soo Lee, Song Cheol Kim, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim
    Surgical Endoscopy.2022; 36(5): 3192.     CrossRef
  • Magnetic Resonance Imaging Radiomics‐Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study
    Zhenshan Shi, Chengle Ma, Xinming Huang, Dairong Cao
    Journal of Magnetic Resonance Imaging.2022; 55(3): 823.     CrossRef
  • Role of Pathologist in the Era of Image-Guided and EUS-Guided Aspirations: A 10-Year Study at a Single Tertiary Care Oncology Institute in North India
    Gurudutt Gupta, Anila Sharma, Meenakshi Kamboj, Anurag Sharma, Sunil Pasricha, Garima Durga, Anurag Mehta, Avinash Rao
    Acta Cytologica.2022; 66(3): 187.     CrossRef
  • Predicting Factors for Pancreatic Malignancy with Computed Tomography and Endoscopic Ultrasonography in Chronic Pancreatitis
    Jian-Han Lai, Keng-Han Lee, Chen-Wang Chang, Ming-Jen Chen, Ching-Chung Lin
    Diagnostics.2022; 12(4): 1004.     CrossRef
  • Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study
    Wei Zhang, Ling Wang, Dan Li, Douglas H. Campbell, Bradley J. Walsh, Nicolle H. Packer, Qing Dong, Erkang Wang, Yuling Wang
    Analytical Methods.2022; 14(23): 2255.     CrossRef
  • Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment
    Wei Zhang, Douglas H. Campbell, Bradley J. Walsh, Nicolle H. Packer, Dingbin Liu, Yuling Wang
    Journal of Nanobiotechnology.2022;[Epub]     CrossRef
  • Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
    Maroun Bou Zerdan, Malek Shatila, Dhruv Sarwal, Youssef Bouferraa, Morgan Bou Zerdan, Sabine Allam, Merima Ramovic, Stephen Graziano
    Cancers.2022; 14(19): 4589.     CrossRef
  • Molecular Subtyping and Precision Medicine for Pancreatic Cancer
    Fieke Froeling, Raffaella Casolino, Antonio Pea, Andrew Biankin, David Chang
    Journal of Clinical Medicine.2021; 10(1): 149.     CrossRef
  • Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
    R. Casolino, C. Braconi, G. Malleo, S. Paiella, C. Bassi, M. Milella, S.B. Dreyer, F.E.M. Froeling, D.K. Chang, A.V. Biankin, T. Golan
    Annals of Oncology.2021; 32(2): 183.     CrossRef
  • Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Adenocarcinomas Revisited. A Detailed Cytological Analysis
    Mrinmay Kumar Mallik, Kusum Kapila, Asit Kumar Mohanty, Shafi Ahmed Inamdar, Ali AlAli, Abdullah Al Naseer
    Journal of Cytology.2021; 38(1): 31.     CrossRef
  • Diagnostic value of various liquid biopsy methods for pancreatic cancer
    Yuzhou Zhu, Hao Zhang, Nan Chen, Jianqi Hao, Hongyu Jin, Xuelei Ma
    Medicine.2020; 99(3): e18581.     CrossRef
  • Factors affecting cytological results of endoscopic ultrasound guided-fine needle aspiration during learning
    Jian-Han Lai, Hsiang-Hung Lin, Ching-Chung Lin
    Diagnostic Pathology.2020;[Epub]     CrossRef
  • Comparison between Conventional Smear and Liquid-Based Preparation in Endoscopic Ultrasonography-Fine Needle Aspiration Cytology of Pancreatic Lesions
    Soo Hee Ko, Jung-Soo Pyo, Byoung Kwan Son, Hyo Young Lee, Il Whan Oh, Kwang Hyun Chung
    Diagnostics.2020; 10(5): 293.     CrossRef
  • Evaluation of Pancreatic Lesions With Endoscopic Ultrasound and Fine Needle Aspiration
    Yan Luk, Wong Hoi She, Felix Che Lok Chow, Ka Wing Ma, Simon Hing Yin Tsang, Wing Chiu Dai, Tan To Cheung, Chung Mau Lo
    Surgical Innovation.2020; 27(5): 431.     CrossRef
  • The applicability of Papanicolaou Society of Cytopathology system on reporting endoscopic ultrasound‐guided fine needle aspiration cytology specimens of pancreatic lesions in situations with limited availability of ancillary tests. Experience at a single
    Mrinmay Kumar Mallik, Laila Rafiq Qadan, Abdullah Al Naseer, Ali AlAli, Taiba Al Ansari, Shafi Ahmed Inamdar Naquib, Dilip Kumar Das, Kusum Kapila
    Cytopathology.2020; 31(6): 564.     CrossRef
  • Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
    Marta Toledano-Fonseca, M. Teresa Cano, Elizabeth Inga, Rosa Rodríguez-Alonso, M. Auxiliadora Gómez-España, Silvia Guil-Luna, Rafael Mena-Osuna, Juan R. de la Haba-Rodríguez, Antonio Rodríguez-Ariza, Enrique Aranda
    Cancers.2020; 12(7): 1754.     CrossRef
  • Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology
    Raza S. Hoda, Elizabeth B. Finer, Ronald N. Arpin, Matthew Rosenbaum, Martha B. Pitman
    Journal of the American Society of Cytopathology.2019; 8(3): 120.     CrossRef
  • Endoscopic ultrasound guided fine‐needle aspiration vs core needle biopsy for solid pancreatic lesions: Comparison of diagnostic accuracy and procedural efficiency
    Aslam Syed, Olivia Babich, Bharat Rao, Shailendra Singh, Neil Carleton, Abhishek Gulati, Archana Kulkarni, Mrinal Garg, Katie Farah, Gursimran Kochhar, Suzanne Morrissey, Marcia Mitre, Abhijit Kulkarni, Manish Dhawan, Jan F. Silverman, Majed Pharaon, Shya
    Diagnostic Cytopathology.2019; 47(11): 1138.     CrossRef
  • Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine
    Claudio Luchini, Nicola Veronese, Alessia Nottegar, Vera Cappelletti, Maria G. Daidone, Lee Smith, Christopher Parris, Lodewijk A. A. Brosens, Maria G. Caruso, Liang Cheng, Christopher L. Wolfgang, Laura D. Wood, Michele Milella, Roberto Salvia, Aldo Scar
    Cancers.2019; 11(8): 1152.     CrossRef
  • It is necessary to exam bottom and top slide smears of EUS-FNA for pancreatic cancer
    Jong-chan Lee, Haeryoung Kim, Hyoung Woo Kim, Jongchan Lee, Kyu-hyun Paik, Jingu Kang, Jin-Hyeok Hwang, Jaihwan Kim
    Hepatobiliary & Pancreatic Diseases International.2018; 17(6): 553.     CrossRef
  • Preoperative EUS-guided FNA: effects on peritoneal recurrence and survival in patients with pancreatic cancer
    Sun Hwa Kim, Young Sik Woo, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Joo Kyung Park, Soo Hoon Kang, Ji Won Kim, Jae Keun Park, Sung-Wook Park
    Gastrointestinal Endoscopy.2018; 88(6): 926.     CrossRef
  • Cytological characteristics of atypical cells in endoscopic ultrasound-guided fine-needle aspiration specimens obtained from the pancreas
    Shikine ESAKA, Yoko MATSUDA, Yuri HAMASHIMA, Masayuki IMAIZUMI, Hiroya KOJIMA, Yuri KISO, Hiroto SHIRAHATA, Mayumi KINOSHITA, Akemi SUZUKI, Tomio ARAI
    The Journal of the Japanese Society of Clinical Cytology.2018; 57(4): 199.     CrossRef
  • Performance measures for endoscopic retrograde cholangiopancreatography and endoscopic ultrasound: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
    Dirk Domagk, Kofi W Oppong, Lars Aabakken, Laszlo Czakó, Tibor Gyökeres, Gianpiero Manes, Peter Meier, Jan-Werner Poley, Thierry Ponchon, Andrea Tringali, Cristina Bellisario, Silvia Minozzi, Carlo Senore, Cathy Bennett, Michael Bretthauer, Cesare Hassan,
    United European Gastroenterology Journal.2018; 6(10): 1448.     CrossRef
  • Performance measures for ERCP and endoscopic ultrasound: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
    Dirk Domagk, Kofi W. Oppong, Lars Aabakken, Laszlo Czakó, Tibor Gyökeres, Gianpiero Manes, Peter Meier, Jan-Werner Poley, Thierry Ponchon, Andrea Tringali, Cristina Bellisario, Silvia Minozzi, Carlo Senore, Cathy Bennett, Michael Bretthauer, Cesare Hassan
    Endoscopy.2018; 50(11): 1116.     CrossRef
  • Imaging modalities for characterising focal pancreatic lesions
    Lawrence MJ Best, Vishal Rawji, Stephen P Pereira, Brian R Davidson, Kurinchi Selvan Gurusamy
    Cochrane Database of Systematic Reviews.2017;[Epub]     CrossRef
  • Percutaneous ultrasound‐guided core needle biopsy of solid pancreatic masses: Results in 250 patients
    Guven Kahriman, Nevzat Ozcan, Serap Dogan, Soner Ozmen, Kemal Deniz
    Journal of Clinical Ultrasound.2016; 44(8): 470.     CrossRef
Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors
Eun-Mi Son, Joo Young Kim, Soyeon An, Ki-Byung Song, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong
J Pathol Transl Med. 2015;49(1):30-36.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.23
  • 10,733 View
  • 101 Download
  • 19 Web of Science
  • 18 Crossref
AbstractAbstract PDF
Background
Pancreatic neuroendocrine tumors (PanNETs) are malignant endocrine neoplasms that present diverse clinical behaviors. Therefore, identification of biomarkers of PanNETs is important for stratification of the prognosis of PanNET patients. Recently, cytokeratin 19 (CK19) and KIT expression were reported to have prognostic significance in PanNET patients. Methods: To identify their prognostic significance, CK19 and KIT protein expression were assessed in 182 surgically resected PanNETs and compared with clinicopathologic factors. Results: Of 182 PanNETs cases, CK19 and KIT expression was noted in 97 (53.3%) and 16 (8.8%) cases, respectively. PanNET patients with CK19 expression had larger tumors (p=.006), higher World Health Organization (WHO) grade (p=.002) and pT classification (p<.001), increased distant metastasis (p=.004), and lymphovascular (p=.012) and perineural (p=.019) invasion. Similarly, those with KIT expression had larger tumors (p=.030), higher WHO grade (p=.001), advanced pT classification (p<.001), distant metastasis (p=.001), and lymphovascular invasion (p=.014). The 5-year survival rate for PanNET patients with KIT expression was significantly lower (62%) than that of patients without KIT expression (77%, p=.011), as determined by univariate but not by multivariate analyses. Conclusions: CK19 and KIT expression correlate with higher metastatic potential and advanced disease stage, and KIT expression is associated with worse survival in PanNET patients.

Citations

Citations to this article as recorded by  
  • Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy
    Kahoko Maeda, Takeshi Uehara, Waki Hosoda, Yasuhiro Kuraishi, Hiroyoshi Ota
    Pathology - Research and Practice.2024; 262: 155537.     CrossRef
  • Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine Tumor
    Bokyung Ahn, Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2023; 147(1): 100.     CrossRef
  • Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
    Chengcao Sun, Youqiong Ye, Zhi Tan, Yuan Liu, Yajuan Li, Wei Hu, Ke Liang, Sergey D. Egranov, Lisa Angela Huang, Zhao Zhang, Yaohua Zhang, Jun Yao, Tina K. Nguyen, Zilong Zhao, Andrew Wu, Jeffrey R. Marks, Abigail S. Caudle, Aysegul A. Sahin, Jianjun Gao,
    Science Advances.2023;[Epub]     CrossRef
  • Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors
    Anne Menz, Rifka Bauer, Martina Kluth, Clara Marie von Bargen, Natalia Gorbokon, Florian Viehweger, Maximilian Lennartz, Cosima Völkl, Christoph Fraune, Ria Uhlig, Claudia Hube-Magg, Noémi De Wispelaere, Sarah Minner, Guido Sauter, Simon Kind, Ronald Simo
    Human Pathology.2021; 115: 19.     CrossRef
  • The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities
    Kate Young, Naureen Starling, Anguraj Sadanandam
    Seminars in Cancer Biology.2020; 61: 132.     CrossRef
  • Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours
    Joo Young Kim, Jacqueline A. Brosnan-Cashman, Jiyoon Kim, Soyeon An, Kyoung-Bun Lee, Haeryoung Kim, Do Youn Park, Kee-Taek Jang, Young-Ha Oh, Ralph H. Hruban, Christopher M. Heaphy, Seung-Mo Hong
    Pathology.2020; 52(3): 336.     CrossRef
  • Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification
    Yue Xue, Michelle D. Reid, Burcin Pehlivanoglu, Rebecca C. Obeng, Hongmei Jiang, Bahar Memis, Shu K. Lui, Juan Sarmiento, David Kooby, Shishir K. Maithel, Bassel El-Rayes, Olca Basturk, Volkan Adsay
    Endocrine Pathology.2020; 31(3): 239.     CrossRef
  • Histological grades and prognostic markers of well-differentiated pancreatic neuroendocrine tumor (WDPNET)
    Yongchao Li, Daniel Rowan, Claire P. Williamson, Meiyun Fan, Ali G. Saad, Lizhi Zhang
    Journal of Pancreatology.2020; 3(4): 188.     CrossRef
  • Clinical and histopathologic prognostic implications of the expression of cytokeratins 8, 10, 13, 14, 16, 18 and 19 in oral and oropharyngeal squamous cell carcinoma
    Rima A. Safadi, Niveen I. Abdullah, Rolla F. Alaaraj, Dima H. Bader, Darshan D. Divakar, Abed A. Hamasha, Maher A. Sughayer
    Archives of Oral Biology.2019; 99: 1.     CrossRef
  • Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
    Lingaku Lee, Tetsuhide Ito, Robert T Jensen
    Expert Review of Anticancer Therapy.2019; 19(12): 1029.     CrossRef
  • Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival
    Joo Young Kim, Sang Hwa Lee, Soyeon An, Sung Joo Kim, You-Na Sung, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Seung-Mo Hong
    Virchows Archiv.2018; 472(5): 739.     CrossRef
  • CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses
    Yasuhiro Sakai, Seung-Mo Hong, Soyeon An, Joo Young Kim, Denis Corbeil, Jana Karbanová, Kyoko Otani, Kohei Fujikura, Ki-Byung Song, Song Cheol Kim, Masayuki Akita, Yoshihide Nanno, Hirochika Toyama, Takumi Fukumoto, Yonson Ku, Takanori Hirose, Tomoo Itoh,
    Human Pathology.2017; 61: 148.     CrossRef
  • Prognostic and predictive biomarkers in neuroendocrine tumours
    David L. Chan, Stephen J. Clarke, Connie I. Diakos, Paul J. Roach, Dale L. Bailey, Simron Singh, Nick Pavlakis
    Critical Reviews in Oncology/Hematology.2017; 113: 268.     CrossRef
  • Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients
    Sung Joo Kim, Soyeon An, Jae Hoon Lee, Joo Young Kim, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong
    Journal of Pathology and Translational Medicine.2017; 51(4): 388.     CrossRef
  • Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis
    Dong Cen, Jiang Chen, Zheyong Li, Jie Zhao, Xiujun Cai, Aamir Ahmad
    PLOS ONE.2017; 12(11): e0187588.     CrossRef
  • A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases
    Liangtao Ye, Huilin Ye, Quanbo Zhou, Zhihua Li, Qing Lin, Langping Tan, Wenchao Gao, Zhiqiang Fu, Shangyou Zheng, Rufu Chen
    International Journal of Surgery.2016; 29: 108.     CrossRef
  • Correlating and Combining Genomic and Proteomic Assessment withIn VivoMolecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
    Bhakti Basu, Sandip Basu
    Cancer Biotherapy and Radiopharmaceuticals.2016; 31(3): 75.     CrossRef
  • Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts
    Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2016; 140(5): 437.     CrossRef
Brief Case Report
Pulmonary Hodgkin Lymphoma in a Patient with Crohn’s Disease
Jae-Young Park, Juhie Lee
Korean J Pathol. 2014;48(5):387-389.   Published online October 27, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.5.387
  • 6,225 View
  • 34 Download
  • 2 Crossref
PDF

Citations

Citations to this article as recorded by  
  • The Complex Relationship between Mechanisms Underlying Inflammatory Bowel Disease, Its Treatment, and the Risk of Lymphomas: A Comprehensive Review
    Katarzyna Stasik, Rafał Filip
    International Journal of Molecular Sciences.2024; 25(8): 4241.     CrossRef
  • Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features
    A. Dohan, S.A. Faraoun, M. Barral, Y. Guerrache, M. Boudiaf, X. Dray, C. Hoeffel, M. Allez, O. Farges, L. Beaugerie, T. Aparicio, P. Marteau, E.K. Fishman, O. Lucidarme, C. Eveno, M. Pocard, R. Dautry, P. Soyer
    Diagnostic and Interventional Imaging.2015; 96(9): 871.     CrossRef
Review & Perspective
Acinar Cell Carcinoma of the Pancreas: Clinical and Cytomorphologic Characteristics
Adam D. Toll, Ralph H. Hruban, Syed Z. Ali
Korean J Pathol. 2013;47(2):93-99.   Published online April 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.2.93
  • 14,912 View
  • 103 Download
  • 22 Crossref
AbstractAbstract PDF

Acinar cell carcinoma is a rare malignant epithelial neoplasm with predominantly exocrine acinar differentiation and is seen primarily in older men (mean age, 62 years). The presenting symptoms are usually non-specific, and jaundice is often not present. Symptoms relating to the overproduction and release of lipase into the circulation are present in 10-15% of patients. Characteristic cytomorphologic features include a population of cells with minimal pleomorphism, eccentrically placed nuclei with a single prominent nucleoli and moderate hyperchromasia. The cytoplasm is finely granular, and the background may contain granular debris secondary to cytolysis. A significant proportion of the cases also have a minor neuroendocrine component or scattered neuroendocrine cells. Approximately 50% of patients have metastatic disease at presentation, often restricted to the regional lymph nodes and liver. The prognosis is poor, only slightly better than that of pancreatic ductal adenocarcinoma.

Citations

Citations to this article as recorded by  
  • Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment
    Kenji Ikezawa, Makiko Urabe, Yugo Kai, Ryoji Takada, Hirofumi Akita, Shigenori Nagata, Kazuyoshi Ohkawa
    Japanese Journal of Clinical Oncology.2024; 54(3): 271.     CrossRef
  • Liquid-based cytology features of pancreatic acinar cell carcinoma: comparison with other non-ductal neoplasms of the pancreas
    Minji Kwon, Seung-Mo Hong, Kyoungbun Lee, Haeryoung Kim
    Journal of Pathology and Translational Medicine.2024; 58(4): 182.     CrossRef
  • A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?
    Victor Hugo Fonseca de Jesus, Mauro Daniel Spina Donadio, Ângelo Borsarelli Carvalho de Brito, Arthur Conelian Gentilli
    Therapeutic Advances in Medical Oncology.2024;[Epub]     CrossRef
  • Misunderstood Gastric Perforation of a Pancreatic Acinar Cell Carcinoma: A Wolf in Sheep’s Clothing
    Manuela Cuoghi, Cinzia Baccaro, Noemi Zorzetti, Adele Fornelli, Francesco Ferrara, Vincenzo Cennamo, Giuseppe Giovanni Navarra
    Surgeries.2023; 4(1): 73.     CrossRef
  • A case of unresectable ectopic acinar cell carcinoma developed in the portal vein in complete response to FOLFIRINOX therapy
    Shinnosuke Nakayama, Akihisa Fukuda, Tadayuki Kou, Manabu Muto, Hiroshi Seno
    Clinical Journal of Gastroenterology.2023; 16(4): 610.     CrossRef
  • Rare Solid Pancreatic Lesions on Cross-Sectional Imaging
    Ana Veron Sanchez, Nuria Santamaria Guinea, Silvia Cayon Somacarrera, Ilias Bennouna, Martina Pezzullo, Maria Bali
    Diagnostics.2023; 13(16): 2719.     CrossRef
  • Pancreatic acinar cell carcinoma: A comprehensive review
    Luis Fernando Calimano-Ramirez, Taher Daoud, Dheeraj Reddy Gopireddy, Ajaykumar C Morani, Rebecca Waters, Kazim Gumus, Albert Russell Klekers, Priya R Bhosale, Mayur K Virarkar
    World Journal of Gastroenterology.2022; 28(40): 5827.     CrossRef
  • Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature
    Cha Len Lee, Spring Holter, Ayelet Borgida, Anna Dodd, Stephanie Ramotar, Robert Grant, Kristy Wasson, Elena Elimova, Raymond W Jang, Malcolm Moore, Tae Kyoung Kim, Korosh Khalili, Carol-Anne Moulton, Steven Gallinger, Grainne M O’Kane, Jennifer J Knox
    World Journal of Gastroenterology.2022; 28(45): 6420.     CrossRef
  • Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature
    Cha Len Lee, Spring Holter, Ayelet Borgida, Anna Dodd, Stephanie Ramotar, Robert Grant, Kristy Wasson, Elena Elimova, Raymond W Jang, Malcolm Moore, Tae Kyoung Kim, Korosh Khalili, Carol-Anne Moulton, Steven Gallinger, Grainne M O’Kane, Jennifer J Knox
    World Journal of Gastroenterology.2022; 28(45): 6421.     CrossRef
  • Pancreatic Acinar Cell Carcinoma with Germline BRCA2 Mutation and Severe Pancreatic Panniculitis: A Case Report
    Lena Dreikhausen, Nadine Schulte, Sebastian Belle, Philip Weidner, Johannes Moersdorf, Christoph Reissfelder, Matthias P. Ebert, Tianzuo Zhan
    Visceral Medicine.2021; 37(5): 447.     CrossRef
  • The Unusual Suspects of the Pancreas—Understanding Pancreatic Acinar Cell Carcinomas and Adenomas
    Andreas Minh Luu, Tim Fahlbusch, Johanna Munding, Waldemar Uhl, Chris Braumann
    Journal of Gastrointestinal Cancer.2020; 51(1): 172.     CrossRef
  • The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study
    Nie Duorui, Bin Shi, Tao Zhang, Chuyao Chen, Chongkai Fang, Zhijun Yue, Peng Wu, Zhiming Wu, Xuewu Huang, Meng Li, Girijesh Kumar Patel
    PLOS ONE.2020; 15(12): e0243164.     CrossRef
  • Metastatic pancreatic acinar cell carcinoma in a younger male with marked AFP production: A potential pitfall on fine needle aspiration biopsy
    Kari Valente, George Yacoub, James O. Cappellari, Graham Parks
    Diagnostic Cytopathology.2017; 45(2): 133.     CrossRef
  • Establishment and characterization of a new human acinar cell carcinoma cell line, Faraz-ICR, from pancreas
    Marzieh Rezaei, Ahmad Hosseini, Saman Nikeghbalian, Abbas Ghaderi
    Pancreatology.2017; 17(2): 303.     CrossRef
  • Multimodal approach and long-term survival in a patient with recurrent metastatic acinar cell carcinoma of the pancreas: A case report
    Sarah F. Jauch, Van K. Morris, Corey T. Jensen, Ahmed O. Kaseb
    Pancreatology.2016; 16(1): 153.     CrossRef
  • Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis
    Michelle D. Reid, Christina R. Stallworth, Melinda M. Lewis, Gizem Akkas, Bahar Memis, Olca Basturk, Volkan Adsay
    Cancer Cytopathology.2016; 124(2): 122.     CrossRef
  • Skin Metastases: The Visible Face of a Disastrous Unusual Finding
    Sílvia Giestas, Adriano Casela, Cláudia Agostinho, Paulo Souto, Ernestina Camacho, M. Julião, Maria Augusta Cipriano, Carlos Sofia
    GE Portuguese Journal of Gastroenterology.2016; 23(5): 282.     CrossRef
  • Acinar Cell Carcinoma of the Pancreas: A Literature Review and Update
    Poras Chaudhary
    Indian Journal of Surgery.2015; 77(3): 226.     CrossRef
  • Acinar Cell Carcinoma of the Pancreas
    Stephanie Simmons, Isam A. Eltoum
    Pathology Case Reviews.2015; 20(4): 192.     CrossRef
  • Brush cytology of acinar cell carcinoma of the pancreas with intraductal growth
    Yasuhiro Toyonaga, Kazuto Yamazaki, Masatoshi Yamada, Takayoshi Koyasu, Yoshinori Koyama, Yasuo Ishida
    Diagnostic Cytopathology.2014; 42(4): 321.     CrossRef
  • DNA Mismatch Repair Abnormalities in Acinar Cell Carcinoma of the Pancreas
    Weiguo Liu, Jinru Shia, Mithat Gönen, Maeve A. Lowery, Eileen M. O’Reilly, David S. Klimstra
    Pancreas.2014; 43(8): 1264.     CrossRef
  • Tumeurs acinaires du pancréas : particularités pronostiques. A propos de 4 cas
    Z. Mzoughi, N. Azzabou, N. Miloudi, L. Gharbi, M. T. Khalfallah
    Journal Africain d'Hépato-Gastroentérologie.2014; 8(3): 113.     CrossRef
Case Report
Adenocarcinoma with Intraductal Papillary Mucinous Neoplasm Arising in Jejunal Heterotopic Pancreas
Ju Young Song, Jee Young Han, Sun Keun Choi, Lucia Kim, Suk Jin Choi, In Suh Park, Young Chae Chu, Kyu Ho Kim, Joon Mee Kim
Korean J Pathol. 2012;46(1):96-100.   Published online February 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.1.96
  • 8,450 View
  • 61 Download
  • 14 Crossref
AbstractAbstract PDF

A 74-year-old man suffered from jejunal perforation and adhesion to sigmoid colon due to adenocarcinoma associated with intraductal papillary mucinous neoplasm (IPMN) arising in a jejunal heterotopic pancreas. The jejunal lesion showed direct extension to the sigmoid colon, which was mistaken as sigmoid colon cancer by surgeons. Malignant transformation is a rare complication of a heterotopic pancreas. About half of malignancies in reported cases were ductal adenocarcinoma arising in the stomach, and the jejunal location is extremely rare. Furthermore, IPMN is also uncommon finding in a heterotopic pancreas.

Citations

Citations to this article as recorded by  
  • Intraductal Papillary Mucinous Neoplasm Arising from Heterotopic Pancreas in Stomach: A Case Report and Review of Literature
    Yu Pang, Yuyu Liu, Qinqin Liu, Gang Hou
    International Journal of Surgical Pathology.2023; 31(5): 708.     CrossRef
  • Clinicopathological features of intraductal papillary mucinous neoplasm derived from ectopic pancreas: A systematic review
    Jiro Kimura, Takehiro Okabayashi, Kenta Sui, Takahiro Murokawa, Motoyasu Tabuchi, Masaki Aida, Jun Iwata, Yasuhiro Hata
    Surgery Open Science.2022; 8: 62.     CrossRef
  • Clinicopathological Features of Intraductal Papillary Mucinous Neoplasm Derived from Ectopic Pancreas: A Systematic Review
    Jiro Kimura, Takehiro Okabayashi, Kenta Sui, Takahiro Murokawa, Motoyasu Tabuchi, Masaki Aida, Jun Iwata, Yasuhiro Hata
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • A case of ectopic pancreas of the stomach accompanied by intraductal papillary mucinous neoplasm with GNAS mutation
    Naoko Nambu, Takashi Yamasaki, Nami Nakagomi, Tsutomu Kumamoto, Tatsuro Nakamura, Akio Tamura, Toshihiko Tomita, Hiroto Miwa, Hisashi Shinohara, Seiichi Hirota
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • Intraductal Papillary Mucinous Neoplasm Arising in a Heterotopic Pancreas Treated by Percutaneous Endoscopic Intragastric Surgery
    Shoko Moue, Yoshimasa Akashi, Koichi Ogawa, Katsuji Hisakura, Tsuyoshi Enomoto, Yusuke Ohara, Yohei Owada, Shingo Sakashita, Tatsuya Oda
    The Japanese Journal of Gastroenterological Surgery.2020; 53(4): 371.     CrossRef
  • Adenocarcinoma with intraductal papillary mucinous neoplasm arising in a duodenal heterotopic pancreas: a case report
    Etsuko Hisanaga, Takaaki Sano, Norio Kubo, Norihiro Ishii, Ken Shirabe, Hitoshi Takagi, Junko Hirato, Hayato Ikota
    Clinical Journal of Gastroenterology.2020; 13(6): 1373.     CrossRef
  • Malignant Transformation of Ectopic Pancreas
    Irina M. Cazacu, Adriana Alexandra Luzuriaga Chavez, Graciela M. Nogueras Gonzalez, Adrian Saftoiu, Manoop S. Bhutani
    Digestive Diseases and Sciences.2019; 64(3): 655.     CrossRef
  • Anomalien im pankreatikobiliären System
    Dirk Walter, Michael Jung
    Der Gastroenterologe.2019; 14(4): 301.     CrossRef
  • Intraductal papillary mucinous neoplasm originating from a heterotopic pancreas within the jejunum: a case report
    Eiji Noda, Kenji Kuroda, Tomohisa Sera, Takuya Mori, Haruhito Kinoshita, Tsuyoshi Hasegawa, Hitoshi Teraoka, Takaaki Chikugo
    Journal of Surgical Case Reports.2018;[Epub]     CrossRef
  • Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions
    Sun-Young Jun, Dahye Son, Mi-Ju Kim, Sung Joo Kim, Soyeon An, Young Soo Park, Sook Ryun Park, Kee Don Choi, Hwoon-Yong Jung, Song Cheol Kim, Jeong Hwan Yook, Byung-Sik Kim, Seung-Mo Hong
    American Journal of Surgical Pathology.2017; 41(6): 833.     CrossRef
  • Heterotopic Pancreas within the Proximal Hepatic Duct, Containing Intraductal Papillary Mucinous Neoplasm
    Alistair J. Lawrence, Aducio Thiessen, Amy Morse, A. M. James Shapiro
    Case Reports in Surgery.2015; 2015: 1.     CrossRef
  • Bowel Rest
    Payal Saxena, Deborah Belchis, Anne Marie Lennon
    Clinical Gastroenterology and Hepatology.2015; 13(13): e173.     CrossRef
  • Adenocarcinoma arising from jejunal ectopic pancreas mimicking peritoneal metastasis from colon cancer: a case report and literature review
    Yusuke Yamaoka, Tomohiro Yamaguchi, Yusuke Kinugasa, Akio Shiomi, Hiroyasu Kagawa, Yushi Yamakawa, Masakatsu Numata, Shinya Sugimoto, Kenichiro Imai, Kinichi Hotta, Keiko Sasaki
    Surgical Case Reports.2015;[Epub]     CrossRef
  • Intraductal papillary mucinous neoplasm of the ileal heterotopic pancreas in a patient with hereditary non-polyposis colorectal cancer: A case report
    Sang Hwa Lee
    World Journal of Gastroenterology.2015; 21(25): 7916.     CrossRef
Original Article
Fine Needle Aspiration Cytology of Solid and papillary Neoplasm of the Pancreas: Report of a Case.
Mee Yon Cho, Kwang Gil Lee, Kyi Beom Lee, Hyeun Joo Jeong, Woo Hee Jung
Korean J Cytopathol. 1990;1(1):85-92.
  • 1,473 View
  • 21 Download
AbstractAbstract PDF
We present the cytologic features of a case of solid and papillary neoplasm of the pancreas. Cytologically, the tumor was composed of a monotonous population of polygonal cells containing ecentrically located round nuclei with one or two distinct small nucleoli and a finely stippled chromatin pattern. The tumor cells were similar to those of the islet cell tumor and showed isolated loosety aggregated and solid sheedts or large cell clumps. The large cell clumps revealed a branching papillary structure containing fibrovascular central core, which is characteristic histologic feature of solid and papillary neoplasm of the pancreas. The case was confirmed by tissue examination including histochemical immunohistochemical and electron microscopical studies. Utrastructurally, the tumor cells contanined a few membrane-bound electron dense granules.
Case Report
Simultaneous Pancreatic Serous Microcystic Adenoma and Intraductal Papillary Mucinous Tumor of the Pancreas: A Case Report.
Hyoung Jong Kwak, Young Kon Kim, Baik Hwan Cho, Woo Sung Moon
Korean J Pathol. 2011;45:S29-S31.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.S1.S29
  • 2,840 View
  • 23 Download
AbstractAbstract PDF
Serous cystadenomas of the pancreas account for approximately a third of pancreatic cystic neoplasms. Their coexistence with a second tumor is extremely rare. We now report a case of a serous microcystic adenoma combined with an intraductal papillary mucinous tumor of the pancreas in a 69-year-old man. Abdominal computed tomography scans demonstrated an incidental cystic mass in the body with cystic dilatation of the duct in the head of the pancreas. Central pancreatectomy with pancreatico-jejunostomy, and cyst excision of the pancreatic head were performed. Histologic examination demonstrated a serous microcystic cystadenoma in the body coexisting with an intraductal papillary mucinous adenoma in the head of the pancreas. This case study highlights the importance of careful intra-operative and pathologic examination for synchronous pancreatic tumors.
Original Article
Clinical Outcome of Surgically Resected Pancreatic Intraductal Papillary Mucinous Neoplasm According to the Marginal Status: A Single Center Experience.
Sun A Kim, Eunsil Yu, Song Cheol Kim, Jihun Kim
Korean J Pathol. 2010;44(4):410-419.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.4.410
  • 3,464 View
  • 22 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
Surgical resection is the treatment of choice of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. However, the benefit of clearing resection margin is still controversial.
METHODS
We reviewed 281 surgically resected cases of IPMN. The recurrences were compared according to the histologic grade (benign or borderline IPMN, malignant noninvasive IPMN, invasive carcinoma) and size (pancreatic intraepithelial neoplasia, PanIN, less than 0.5 cm in the long axis; and IPMN, greater than or equal to 0.5 cm) of the residual lesions at the resection margin.
RESULTS
Sixty cases (21.4%) were invasive carcinoma, and 221 (78.6%) noninvasive cases included 87 (31.0%) benign, 107 (38.1%) borderline and 11 (3.9%) malignant noninvasive IPMN cases. In noninvasive IPMN, increased recurrence in patients with five or more years of follow-up was only related to the involvement of resection margin by severe dysplasia. The recurrence of invasive carcinoma was high (27.3%) even when the resection margin was clear, and was not related to the grade or size of residual tumors at the resection margin.
CONCLUSIONS
Invasiveness is a strong risk factor for recurrence in IPMN regardless of the status of the resection margin. However, in noninvasive IPMN, histologic grading of residual lesions at the resection margin predicts local recurrence.

Citations

Citations to this article as recorded by  
  • Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms
    Laura D. Wood, N. Volkan Adsay, Olca Basturk, Lodewijk A.A. Brosens, Noriyoshi Fukushima, Seung-Mo Hong, Sung-Joo Kim, Jae W. Lee, Claudio Luchini, Michaël Noë, Martha B. Pitman, Aldo Scarpa, Aatur D. Singhi, Mariko Tanaka, Toru Furukawa
    Pancreatology.2023; 23(7): 878.     CrossRef
  • The Use of Intraoperative Frozen Sections in Guiding the Extent of Pancreatic Resections for Intraductal Papillary Mucinous Neoplasms
    Zhikai Chi, Deepti Dhall, Richard Mertens
    Pancreas.2022; 51(1): 63.     CrossRef
  • Recurrence of non-invasive intraductal papillary municious neoplasm seven years following total pancreatectomy
    Nayima M. Clermont Dejean, Sinziana Dumitra, Jeffrey S. Barkun
    International Journal of Surgery Case Reports.2013; 4(9): 789.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP